Implantable defibrillators for prevention of sudden death. Technology at a medical and economic crossroad.
Implantable defibrillators for prevention of sudden death. Technology at a medical and economic crossroad.
复制标题
用于预防猝死的植入式除颤器。
DOI：
10.1161/01.cir.85.6.2316
复制
发表时间：
1992
期刊：
影响因子：
37.8
通讯作者：
A. Camm
中科院分区：
文献类型：
--
作者：
S. Saksena;A. Camm
植入式心律转复除颤器治疗目前被广泛用于治疗有症状的有记录或疑似危及生命的VT患者。虽然ICD接受者的猝死复发几乎被消除，但该患者人群的心源性死亡率和总生存率方面的获益程度仍有待准确定量，特别是与替代抗心律失常治疗相比。先进的器械和电极导线系统有望进一步改善患者的生存率和植入后的生活质量。ICD治疗中无限制增殖的经济影响可能是巨大的;然而，现有的成本效益分析支持明智地使用这种治疗，其经济影响与其他公认的心血管治疗相当。当考虑将其应用扩展到未来心脏骤停潜在风险的无症状或症状轻微人群时，这种前瞻性风险分层在经济上变得至关重要。
Implantable cardioverter-defibrillator therapy is now widely used for the treatment of symptomatic patients with documented or suspected life-threatening VTs. Although sudden death recurrence in ICD recipients is virtually eliminated, the extent of benefit both with respect to cardiac mortality and total survival in this patient population remains to be accurately quantitated, particularly vis-à-vis alternative antiarrhythmic therapies. Advanced device and lead systems can be expected to further improve both patient survival and quality of life after implant. The economic impact of unrestrained proliferation in ICD therapy can be enormous; however, available cost-benefit analyses support judicious use of this therapy with comparable economic impact to other accepted cardiovascular therapies. Such prospective risk stratification becomes economically essential when considering expanding its application to asymptomatic or minimally symptomatic populations at potential risk for future cardiac arrest.
植入式心脏复律除颤器的未来研究。
DOI：
10.1111/j.1540-8159.1991.tb04129.x
发表时间：
1991
期刊：
Pacing and clinical electrophysiology : PACE
影响因子：
--
作者：
BiggerJr,JT
通讯作者：
BiggerJr,JT
植入自动除颤器的患者的死亡率。
影响因子：
39.2
作者：
Mirowski,M;Reid,PR;Winkle,RA;Mower,MM;WatkinsJr,L;Stinson,EB;Griffith,LS;Kallman,CH;Weisfeldt,ML
通讯作者：
Weisfeldt,ML
当“心源性猝死”不再那么突然时：自动植入式除颤器的教训。
影响因子：
4.8
作者：
Guarnieri,T;Levine,JH;Griffith,LS;Veltri,EP
通讯作者：
Veltri,EP